A Study to Evaluate the Pharmacokinetic Exposure of 2 Formulations of Apremilast in Healthy Adults

NCT02777554 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Apremilast IR
DRUG: Apremilast XL

Sponsor

Amgen